Healing the mental health crisis: The emerging potential of psychedelics
With 1 in 4 people experiencing mental health issues worldwide, we ask this incredible panel of health and tech luminaries, can we solve the mental health crisis with psychedelics? Featuring: Catherine Bird – Clinical Trials Manager – Psychedelic Trials Group, King’s College London Christian Angermayer – Co-founder & Chairman – Apeiron Investment Group Dr Ekaterina […]